» Articles » PMID: 23145007

Plasma Clot Lysis Time and Its Association with Cardiovascular Risk Factors in Black Africans

Overview
Journal PLoS One
Date 2012 Nov 13
PMID 23145007
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Studies in populations of European descent show longer plasma clot lysis times (CLT) in patients with cardiovascular disease (CVD) than in controls. No data are available on the association between CVD risk factors and fibrinolytic potential in black Africans, a group undergoing rapid urbanisation with increased CVD prevalence. We investigated associations between known CVD risk factors and CLT in black Africans and whether CLTs differ between rural and urban participants in light of differences in CVD risk.Data from 1000 rural and 1000 urban apparently healthy black South Africans (35-60 years) were cross-sectionally analysed.Increased PAI-1(act), BMI, HbA1c, triglycerides, the metabolic syndrome, fibrinogen concentration, CRP, female sex and positive HIV status were associated with increased CLTs, while habitual alcohol consumption associated with decreased CLT. No differences in CLT were found between age and smoking categories, contraceptive use or hyper- and normotensive participants. Urban women had longer CLT than rural women while no differences were observed for men.CLT was associated with many known CVD risk factors in black Africans. Differences were however observed, compared to data from populations of European descent available in the literature, suggesting possible ethnic differences. The effect of urbanisation on CLT is influenced by traditional CVD risk factors and their prevalence in urban and rural communities.

Citing Articles

HbA1c comparable to fasting glucose in the external validation of the African Diabetes Risk Score and other established risk prediction models in Black South Africans.

Royce N, Cronje H, Kengne A, Kruger H, Dolman-Macleod R, Pieters M BMC Endocr Disord. 2024; 24(1):213.

PMID: 39390433 PMC: 11465613. DOI: 10.1186/s12902-024-01735-w.


HIV infection and ART use are associated with altered plasma clot characteristics in Black South Africans.

Bakali S, de Lange-Loots Z, Jordaan A, Pieters M PLoS One. 2024; 19(6):e0305826.

PMID: 38917149 PMC: 11198788. DOI: 10.1371/journal.pone.0305826.


Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.

Zabczyk M, Ariens R, Undas A Cardiovasc Res. 2023; 119(1):94-111.

PMID: 36662542 PMC: 10377755. DOI: 10.1093/cvr/cvad017.


Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes.

Zabczyk M, Natorska J, Undas A J Clin Med. 2021; 10(13).

PMID: 34279484 PMC: 8268932. DOI: 10.3390/jcm10132999.


The association of alcohol with circulating total fibrinogen and plasma clot density is mediated by fibrinogen and FXIII genotypes.

Rautenbach P, Nienaber-Rousseau C, Pieters M Thromb J. 2020; 18(1):35.

PMID: 33292263 PMC: 7706066. DOI: 10.1186/s12959-020-00249-4.


References
1.
Alessi M, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M . Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes. 2000; 49(8):1374-80. DOI: 10.2337/diabetes.49.8.1374. View

2.
Gorog D . Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease. J Am Coll Cardiol. 2010; 55(24):2701-9. DOI: 10.1016/j.jacc.2009.11.095. View

3.
Ryan E, Mockros L, Weisel J, Lorand L . Structural origins of fibrin clot rheology. Biophys J. 1999; 77(5):2813-26. PMC: 1300553. DOI: 10.1016/S0006-3495(99)77113-4. View

4.
Alessi M, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I . Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes. 1997; 46(5):860-7. DOI: 10.2337/diab.46.5.860. View

5.
Leander K, Blomback M, Wallen H, He S . Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction. Thromb Haemost. 2012; 107(6):1092-9. DOI: 10.1160/TH11-11-0760. View